Fascin actin-bundling protein 1 in human cancer: promising biomarker or therapeutic target?

H Liu, Y Zhang, L Li, J Cao, Y Guo, Y Wu… - Molecular Therapy …, 2021 - cell.com
Fascin actin-bundling protein 1 (FSCN1) is a highly conserved actin-bundling protein that
cross links F-actin microfilaments into tight, parallel bundles. Elevated FSCN1 levels have …

Extracellular proteolysis in glioblastoma progression and therapeutics

A Quesnel, GS Karagiannis, PS Filippou - Biochimica et Biophysica Acta …, 2020 - Elsevier
Gliomas encompass highly invasive primary central nervous system (CNS) tumours of glial
cell origin with an often-poor clinical prognosis. Of all gliomas, glioblastoma is the most …

Surfaceome proteomic of glioblastoma revealed potential targets for immunotherapy

M Rose, T Cardon, S Aboulouard, N Hajjaji… - Frontiers in …, 2021 - frontiersin.org
Glioblastoma (GBM) is the most common and devastating malignant brain tumor in adults.
The mortality rate is very high despite different treatments. New therapeutic targets are …

PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo

EJ Brown, L Balaguer-Lluna, AP Cribbs, M Philpott… - Scientific Reports, 2024 - nature.com
Abstract H3K27-altered Diffuse Midline Glioma (DMG) is a universally fatal paediatric
brainstem tumour. The prevalent driver mutation H3K27M creates a unique epigenetic …

Targeting the ILK/YAP axis by LFG-500 blocks epithelial–mesenchymal transition and metastasis

C Li, J Li, S Gong, M Huang, R Li, G Xiong… - Acta Pharmacologica …, 2021 - nature.com
Metastasis is the main cause of mortality in patients with cancer. Epithelial–mesenchymal
transition (EMT), a crucial process in cancer metastasis, is an established target for …

Hypoxia-induced Fascin-1 upregulation is regulated by Akt/Rac1 axis and enhances malignant properties of liver cancer cells via mediating actin cytoskeleton …

J Pu, Y Huang, Q Fang, J Wang, W Li, Z Xu, X Wu… - Cell Death …, 2021 - nature.com
In solid tumors, hypoxia facilitates malignant progression of cancer cells by triggering
epithelial-mesenchymal transition (EMT) and cancer stemness. Fascin-1, an actin-bundling …

Glioblastoma therapy: State of the field and future prospects

NA Khiabani, MA Doustvandi, D Story, SA Nobari… - Life Sciences, 2024 - Elsevier
Glioblastoma (GB) is a cancerous brain tumor that originates from glial cells and leads to
thousands of deaths each year and a five-year survival of only 6.8%. Treatments for GB …

[HTML][HTML] Circular RNA circ_0000515 adsorbs miR-542-3p to accelerate bladder cancer progression via up-regulating ILK expression

G Peng, J Guan, P Leng, L Peng, M Cao… - Aging (Albany NY …, 2022 - ncbi.nlm.nih.gov
Background: Bladder cancer (BC) is a common cause of cancer-relevant deaths globally.
This study is designed to delve into expressions, biological functions and molecular …

Overview of the molecular mechanisms of migration and invasion in glioblastoma multiforme

X Liu, JY Chen, Y Chien, YP Yang… - Journal of the Chinese …, 2021 - journals.lww.com
Glioblastoma (GBM) is one of the most devastating cancers, with an approximate median
survival of only 16 months. Although some new insights into the fantastic heterogeneity of …

Fascin1 mediated release of pro-inflammatory cytokines and invasion/migration in rheumatoid arthritis via the STAT3 pathway

K Ma, C Zhang, W Li - Cell Cycle, 2021 - Taylor & Francis
Rheumatoid arthritis (RA) is a chronic, multi-factorial disease characterized by Synovial
hyperplasia, chronic inflammation, and autoimmune reaction. Fascin1 overexpression has …